000 01304 a2200385 4500
005 20250518055239.0
264 0 _c20200420
008 202004s 0 0 eng d
022 _a1651-2057
024 7 _a10.2340/00015555-3304
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPallesen, Kristine A U
245 0 0 _aDominant Dystrophic Epidermolysis Bullosa Pruriginosa Responding to Naltrexone Treatment.
_h[electronic resource]
260 _bActa dermato-venereologica
_cNov 2019
300 _a1195-1196 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdult
650 0 4 _aChild
650 0 4 _aCollagen Type VII
_xgenetics
650 0 4 _aEpidermolysis Bullosa Dystrophica
_xdrug therapy
650 0 4 _aGenetic Predisposition to Disease
650 0 4 _aHeredity
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMutation
650 0 4 _aNaltrexone
_xtherapeutic use
650 0 4 _aNarcotic Antagonists
_xtherapeutic use
650 0 4 _aPhenotype
650 0 4 _aSkin
_xdrug effects
650 0 4 _aTreatment Outcome
700 1 _aLindahl, Kim H
700 1 _aBygum, Anette
773 0 _tActa dermato-venereologica
_gvol. 99
_gno. 12
_gp. 1195-1196
856 4 0 _uhttps://doi.org/10.2340/00015555-3304
_zAvailable from publisher's website
999 _c30045732
_d30045732